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ever before have there been so many clinical trials and human studies exa-
ining a wide range of therapeutic approaches for the treatment of spinal cord
njury (SCI). The therapeutic interventions include: 1) drugs to limit the degree of
econdary cell damage after the primary mechanical trauma of SCI, 2) monoclo-
al antibodies to promote axonal sprouting and neuroplasticity, 3) cell transplants
o replace lost neural cells, and 4) activity dependent rehabilitation to facilitate
unctional recovery. The current status for each of these therapeutic approaches,
s well as the strengths and limitations (benefits and risks) for each type of inter-
ention will be summarized. Potential therapeutic options for the future will
lso be discussed, including combination treatments. With increased access to
cientific and medical information via the Internet, patients are now very well
nformed. Consequently, all scientists and clinicians need to answer a wider
cope of questions, ranging from fundamental cell biology to the many claims
or clinical benefits from a seemingly endless number of treatment options. In
rief, all biomedical researchers and health care professionals must now be com-
etent knowledge translators. This means scientists and clinicians must be able
o critically evaluate the quality and strength of evidence provided by different
ypes of preclinical discoveries and human studies, as well as their realistic pros-
ect for clinical application. In brief, human studies without appropriate control
ata and blinded assessments are not pivotal clinical trials and will not vali-
ate an intervention as a treatment. Payment (by a subject) for an experimental
reatment automatically means it is not a clinical trial, as the investigator has
financial incentive (i.e. a bias). The optimal foundations for an ideal clinical
rial program are difficult to guarantee, but several fundamental factors will be
eviewed.
oi:10.1016/j.rehab.2011.07.176
O15-003–EN
tem cell therapies in SCI
. Perrin
Department of Neuroscience, Laboratory: Integrative Biology of
eurodegeneration, Faculty of Medicine, University of the Basque Country,
ampus de Leioa. Ba Sarriena, 48940 Leioa, Spain
eywords: Spinal cord injury; Transplantation; Stem cells
eurological diseases are often due to a loss of cells and/or interruption of
euronal circuits. Moreover, the central nervous system, thus the spinal cord,
as a limited ability to regenerate spontaneously.
tem cells (SC) are not only able to self-renew but also to produce all cell
ypes. Their transplantation into the injured spinal cord is thus considered as a
herapeutic strategy with the final goal of reducing or even abrogate symptoms.
deally, the CS could be used to generate new neurons to replace those that were
ost. In SCI, the simple replacement is not sufficient to restore lost functions;
ew neurons indeed need to reconnect to their intra-or extra-medullary targets.
t seems, at least in a near future, more feasible to use cell transplantation to
rotect dying neurons, to promote their survival, and possibly to stimulate their
egrowth.
ell transplants already performed in humans have unfortunately brought disap-
ointing results. Parallel studies in animals and humans show that cell transplants
ould increase the incidence of neuropathic pain and worsen the neurological
utcomes.
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ervical spinal cord injuries (SCI) frequently induce, in addition to para and
etraplegia, respiratory insufficiencies that constitute major complicating factors
y increasing dependency (assisted ventilation) and probability of post-trauma
eath.
n order to counterbalance respiratory deleterious effects after cervical SCI, we
ested the impact of intra-spinal transplantation of nasal olfactory ensheathing
ells (OEC), a strategy considered as promising for spinal cord repair.
t the respiratory level, our research group set the stage in evidencing
respiratory benefit after acute cervical SCI and OEC transplantation
1].
n the present report, nasal OEC transplantation was performed in conditions
lose to clinical situations, i.e. after a chronic contusion/compression of the
ervical spinal cord [2]. We used a rat model that mimics the mechanisms
ncountered after a C2 cervical contusion/compression that induces a persistent
emi-diaphragmatic paralysis [3]. The respiratory rat model has been used
ince it has now been established that the rodent constitutes an appropriate
reclinical model for treating spinal cord injury, at least for respiratory dysfunc-
ion [4]. In addition, the therapeutic efficiency of nasal OECs injection within
he injured spinal cord was assessed using a delayed transplantation (2 weeks
ost-contusion).
unctional recovery was quantified with respiratory behavior tests, diaphragma-
ic electromyography and neuro-electrophysiological recording of the phrenic
otoneurons while axogenesis was evaluated using immunohistochemistry.
e show that 3 months post-transplantation (i.e. 3.5 months post-injury), nasal
ECs improve i) breathing movements, ii) activities of the ipsilateral diaphragm
nd corresponding phrenic nerve, iii) axonal sprouting in the injury site and
v) the injured area by reducing the cystic size cavities. We also demonstrate
hat this functional partial recovery is mediated by the restoration of ipsilateral
upraspinal command.
n conclusion, this study brings further evidence that olfactory ensheathing cells
ould have clinical application, especially for tetraplegic patients with impaired
reathing movements.
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ultiple sclerosis (MS) is an inflammatory disease of the central nervous sys-
em (CNS) mainly affecting young adults and responsible for demyelinated
atches within the white matter. The existence of an animal model, the experi-
ental acute encephalomyelitis (EAE) based on the immunization of an animal
ith a myelin peptide or protein allowed a better understanding of the cellular
nd molecular actors playing a role in the MS lesions. Thus, peripheral activa-
ion of CD4 + autoreactive T lymphocytes appeared to be a key phenomenon in
he human disease. However, the animal model presents many shortcomings in
xplaining the pathophysiology of MS. Human studies on the blood, cerebrospi-
al fluid or biopsy/autopsic samples are therefore required to better understand
he lesion formation in MS. These studies have thus showed that CD8 + T lym-
hocytes rather than CD4+ T cells probably had a crucial role in MS injury.
ore recently, the involvement of B cells has been demonstrated. Taken toge-
her, from an immunological point of view, the disease appears more complex
han expected. Finally, recent advances in the field of genetics helped discover
bout 50 genes involved in the occurrence of the disease, the majority of them
aving a role in the immune system. Nevertheless, there are still many disco-
eries to be made to modelize MS lesions, in particular the discovery of the
ntigens responsible for the disease. Indeed while the classical hypothesis of
he emergence of MS is a peripheral immunization against CNS antigens, some
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niches, a factor known to affect adult brain neurogenesis.292 Abstract / Annals of Physical and Reha
athological studies suggest that the first events responsible for the lesions could
e held in the CNS.
oi:10.1016/j.rehab.2011.07.179
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bjectif.– Nous avons étudié l’impact d’une lésion spinale cervicale sur les
iches de neurogenèse du cerveau adulte de rat.
atériels et méthodes.– Par la technique d’un « pulse chase » de BrdU couplé
l’étude de la neurogenèse, de l’astrogliose et de la microgliose, nous avons
nvestigué les régions suivantes : la moelle épinière, le complexe vagal dorsal, la
one sous-granulaire de l’hippocampe, la zone sous-ventriculaire du ventricule
atéral et le bulbe olfactif. De plus, une étude de qPCR comparative nous a permis
’explorer le niveau de transcription de cytokines et de chémokines dans les
égions précédentes après la lésion. Les récepteurs CCR2 et CCR5, ainsi que le
acteur de nécrose tumoral alpha 1 (TNF1) ont été respectivement sélectionnés
omme candidats de chémokines et cytokines pour la réponse inflammatoire. Ces
nalyses ont été effectuées pendant les phases subchronique et chronique de la
ésion spinale.
ésultats.– Nous montrons qu’une lésion spinale subchronique 1) diminue la
eurogenèse en altérant la formation de nouveaux neurones dans les régions du
rosencéphale adulte : la zone sous-ventriculaire du ventricule latéral et la zone
ous-granulaire de l’hippocampe ; 2) active la microglie dans le complexe vagal
orsal du rhombencéphale. La neurogenèse reste diminuée dans l’hippocampe
urant la phase chronique. Dans la moelle épinière cervicale, une lésion spinale
ubchronique augmente principalement l’astrogliose et la microgliose, alors que
a neurogenèse est mineure. De plus, pendant la période aiguë de lésion en paral-
èle, nous montrons l’existence d’une réponse inflammatoire dans ces régions
u cerveau. Sachant que l’inflammation est connue pour altérer la neurogenèse
dulte, nous suggérons que ces modulations de dynamique cellulaire dans le
erveau sont probablement liées à une inflammation.
D
d
dtion Medicine 54S (2011) e289–e292
iscussion.– Cette nouvelle observation met en valeur une nouvelle dimension
es dommages d’une lésion spinale à distance de la moelle épinière et démontre
a vulnérabilité du cerveau face à une lésion spinale.
oi:10.1016/j.rehab.2011.07.180
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bjective.– We have investigated the impact of a cervical spinal cord injury
SCI) on adult rat brain neurogenesis niches.
aterial and methods.– We applied a BrdU pulse chase follow-up coupled to
uantification of neurogenesis, astrogliosis and microgliosis during the subchro-
ic (15 days) and chronic (90 days) phases post-injury in the following regions:
he spinal cord, the complex vagal dorsal, the subgranular zone of the hippo-
ampus, the subventricular zone of the lateral ventricule and the olfactory bulb.
e ran comparative qPCR experiments designed to explore the transcriptional
evel of cytokines and chemokines in the previous regions over the time of injury.
he chemokine receptors, CCR2 and CCR5, were respectively selected as astro-
ytes and microglia inflammatory markers while the tumor necrosis-factor alpha
(TNF1) was preferred as a candidate for the cytokine response after SCI.
esults.– We show here that subchronic SCI (1) downregulates neurogenesis by
ltering the formation of newly generated neurons in the adult forebrain regions:
he subventricular zone of the lateral ventricule and the subgranular zone of the
ippocampus; and (2) activates microglia in the dorsal vagal complex of the
indbrain. Neurogenesis remains downregulated in the hippocampus during the
hronic phase. In the cervical spinal cord, subchronic SCI upregulates mainly
strogliosis and microgliosis, while neurogenesis is minor. In parallel, we found
hat during the acute phase, SCI produces inflammation in the brain neurogeniciscussion.– This new observation highlights a new dimension of SCI damage
istal from the spinal cord and demonstrates brain vulnerability to SCI.
oi:10.1016/j.rehab.2011.07.181
